Although it has been suggested that generic substitution of anticonvulsant medication may not result in health care cost savings,1one could argue that we need to look closer at how and when generic drugs are used and the current evidence available prior to making such conclusions. Because most anticonvulsant medications have or soon will have a generic formulation available, it is important to consider whether there is ample evidence to suggest that they are adequate. This article will provide arguments to suggest that generic formulations are a good thing.